Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure
Gennaro Giustino(Cardiovascular Institute of the South), Gregg W. Stone(Cardiovascular Institute of the South), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Stuart Pocock(London School of Hygiene & Tropical Medicine), Björn Redfors(Cornell University), JoAnn Lindenfeld(Brigham and Women's Hospital), Saibal Kar(Bakersfield Heart Hospital), Federico M. Asch(MedStar Washington Hospital Center), William T. Abraham(The Ohio State University), Anton Camaj(Columbia University Irving Medical Center), Samir Kapadia(Cleveland Clinic), David J. Cohen(Baim Institute for Clinical Research), Paul Grayburn(Heart Hospital Baylor Plano), Zhipeng Zhou(Fujian Medical University), D. Scott Lim(University of Virginia Health System)
Cited by 47
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.7k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
|New England Journal of Medicine|2010|3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k